Today 8:41 AM
The Economic Times
Lupin gets tentative USFDA nod for Dolutegravir, Emtricitabine and Tenofovir Alafenamide tablets
The tentative approval by the United States Food and Drug Administration (USFDA) has been granted und... See more »
Emcure: Drugmaker Wants $950M Vaccine Trade Secrets Suit Tossed
India-based Emcure said Friday that it shouldn't have to face a suit launched in Washington federal court claiming it stole secrets for a new COVID-19 vaccine, saying Washington state isn't the right place for the claims.
Read full article »
January 30, 2023
MarketScreener
Cipla : Earnings Call Transcript Q3FY23
(marketscreener.com) "Cipla Limited Q3FY '23 Earnings Conference Call" January 25, 2023 MANAGEMENT: M... See more »
Today 8:41 AM
The Economic Times
Lupin gets tentative USFDA nod for Dolutegravir, Emtricitabine and Tenofovir Alafenamide tablets
The tentative approval by the United States Food and Drug Administration (USFDA) has been granted und... See more »
January 30, 2023
MarketScreener
Cipla : Earnings Call Transcript Q3FY23
(marketscreener.com) "Cipla Limited Q3FY '23 Earnings Conference Call" January 25, 2023 MANAGEMENT: M... See more »
Founder & CEO
Satish Mehta
Emcure is a pharmaceutical firm that manufactures and markets tablets, capsules and injectables.
Read more